Who invested in Illimis Therapeutics?
Illimis Therapeutics's investors include Korea Development Bank, IMM Investment and DSC Investment.
Who invested in Illimis Therapeutics
Funding summaryUpdated 26 Oct 2026
$42Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $42MJul 2025
- Investors
- 3
The rounds
- Jul 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Illimis Therapeutics
How much has Illimis Therapeutics raised?
Illimis Therapeutics has raised $42M across 1 round since 2025.
When did Illimis Therapeutics last raise?
Illimis Therapeutics's most recent round was a Series B of $42M in Jul 2025.
What was Illimis Therapeutics's biggest round?
Its most recent round, $42M in Jul 2025, is also its largest on record.
Who backed Illimis Therapeutics first?
Illimis Therapeutics's first round on record, in Jul 2025, was backed by Korea Development Bank, IMM Investment and DSC Investment.
What stage is Illimis Therapeutics at?
Illimis Therapeutics's latest named round is a Series B, in Jul 2025.
Companies like Illimis Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.